pharma giant’s stock poised for growth amid challenges By Investing.com
AstraZeneca PLC (NASDAQ:LON:), a global biopharmaceutical powerhouse, has been making significant strides in the pharmaceutical industry, particularly in the oncology sector. The company’s recent performance and strategic moves have caught the attention of investors and analysts alike, prompting a closer look at its potential for future growth and the challenges it may face in an increasingly competitive market.
Company Overview
AstraZeneca (NASDAQ:) is a multinational pharmaceutical and biopharmaceutical company with a strong focus on oncology products. The company’s portfolio spans various therapeutic areas, including cardiovascular, renal and metabolism, respiratory, and immunology. AstraZeneca’s commitment to science-led…
